Merck KGaA (ETR:MRK) Shares Down 0.3% – Should You Sell?

Merck KGaA (ETR:MRKGet Free Report) shares were down 0.3% during mid-day trading on Tuesday . The stock traded as low as €153.35 ($168.52) and last traded at €153.60 ($168.79). Approximately 148,117 shares changed hands during trading, The stock had previously closed at €154.05 ($169.29).

Merck KGaA Price Performance

The firm has a market cap of $19.56 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 2.37 and a beta of 0.71. The company has a quick ratio of 0.72, a current ratio of 1.31 and a debt-to-equity ratio of 37.56. The company’s 50-day moving average price is €161.40 and its 200-day moving average price is €161.25.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.